京新药业 (002020.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(京新药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 1,058,822,622.341,089,261,095.121,060,660,180.251,073,297,790.87988,985,036.16976,126,756.05960,425,636.79
 营业收入(元) 1,058,822,622.341,089,261,095.121,060,660,180.251,073,297,790.87988,985,036.16976,126,756.05960,425,636.79
二、营业总成本(元) 872,477,194.37864,963,731.52870,669,357.50933,980,004.93831,447,791.83796,440,712.73805,167,987.13
 营业成本(元) 527,708,413.17530,783,811.53510,338,395.36542,914,722.95475,191,758.44477,988,470.18480,393,479.67
 研发费用(元) 72,419,884.1998,644,187.8898,380,244.05141,478,288.8088,335,330.3690,282,954.3880,838,157.33
 营业税金及附加(元) 11,702,142.4812,479,118.4410,138,702.5916,609,813.3810,197,857.2510,202,486.289,735,151.23
 销售费用(元) 203,791,618.67175,907,259.92207,904,913.74177,640,926.63207,606,156.81197,736,917.77200,543,328.93
 管理费用(元) 66,769,281.2775,630,231.8552,083,952.5370,928,038.9155,692,489.4146,645,926.0239,901,757.29
 财务费用(元) -9,914,145.41-28,480,878.10-8,176,850.77-15,591,785.74-5,575,800.44-26,416,041.90-6,243,887.32
  其中:利息费用(元) 1,164,123.512,356,589.053,737,540.651,076,530.05---
  其中:利息收入(元) 15,890,498.0129,866,650.7911,743,911.2418,330,664.17---
 资产减值损失(元) -1,307,527.663,343,830.11-1,934,674.71-22,626,393.63-1,651,031.08-1,393,858.414,525,850.69
 信用减值损失(元) -5,016,633.53-9,463,564.40-3,153,908.97-5,736,913.953,054,341.34-1,049,768.61-1,405,174.41
三、其他经营收益
 加:公允价值变动收益(元) 40,719.18676,719.18176,705.4835,432,756.25336,171.23405,410.96596,602.74
 加:投资收益(元) 6,101,608.41-1,925,498.681,793,438.35-214,176.532,153,256.401,011,025.143,490,483.26
 资产处置收益(元) 107,486.10237,725.881,673.072,228,715.99305,904.974,415,166.76-90,020.33
 其他收益(元) 9,373,320.1456,950,311.1415,179,922.2230,167,984.669,134,673.266,649,589.7912,519,639.92
四、营业利润(元) 195,644,400.61274,116,886.83202,053,978.19178,569,758.73170,870,560.45189,723,608.95174,895,031.53
 加:营业外收入(元) 2,864,181.914,529,809.17177,638.00569,879.50307,088.761,134,872.17459,535.15
 减:营业外支出(元) 2,166,194.27642,065.28114,336.887,191,929.5070,671.98748,513.83478,427.98
五、利润总额(元) 196,342,388.25278,004,630.72202,117,279.31171,947,708.73171,106,977.23190,109,967.29174,876,138.70
 减:所得税费用(元) 21,653,278.5745,346,444.3828,905,146.7024,482,420.1813,601,865.3723,411,272.7523,127,660.79
六、净利润(元) 174,689,109.68232,658,186.34173,212,132.61147,465,288.55157,505,111.86166,698,694.54151,748,477.91
(一)按经营持续性分类
  持续经营净利润(元) 174,689,109.68232,658,186.34173,212,132.61147,656,178.49157,505,111.86166,698,694.54151,748,477.91
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 172,890,109.64230,914,839.24171,207,841.45146,274,498.33156,699,380.93164,726,110.95151,198,043.53
  少数股东损益(元) 1,799,000.041,743,347.102,004,291.161,190,790.22805,730.931,972,583.59550,434.38
 扣除非经常性损益后的净利润(元) 159,767,636.84177,494,479.42156,941,537.0096,305,045.08146,390,169.67153,043,473.90137,301,166.62
七、每股收益
 一、基本每股收益(元) 0.200.270.200.170.180.190.18
 二、稀释每股收益(元) 0.200.270.200.170.180.190.18
八、其他综合收益(元) -178,652.52101,183.61284,399.46-1,014,666.02105,916.71423,553.67151,432.72
 归属于母公司股东的其他综合收益(元) -175,055.35107,310.37274,282.49-1,001,507.77102,580.59428,883.29136,141.55
 归属于少数股东的其他综合收益(元) -3,597.17-6,126.7610,116.97-13,158.253,336.12-5,329.6215,291.17
九、综合收益总额(元) 174,510,457.16232,759,369.95173,496,532.07146,450,622.53157,611,028.57167,122,248.21151,899,910.63
 归属于母公司所有者的综合收益总额(元) 172,715,054.29231,022,149.61171,482,123.94145,272,990.56156,801,961.52165,154,994.24151,334,185.08
 归属于少数股东的综合收益总额(元) 1,795,402.871,737,220.342,014,408.131,177,631.97809,067.051,967,253.97565,725.55
公告日期 2024-10-252024-08-152024-04-242024-03-302023-10-272023-08-152023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院